SSJR Logo

NOTE: SSJR.com uses cookies for browser optimization and analytics. Click here to learn about our privacy policy.

Jenny Deng

Bio View in: English | 中文

Ms. Deng is an IP lawyer and Head of China Practice Group at SSJR. Her practice focuses on patent preparation and prosecution; opinion work including (non)infringement, invalidity, patentability, and FTO opinions, as well as Hatch-Waxman patent certifications; patent-related due diligence and agreement review. She assists clients in managing their patent portfolios and designing around blocking patents. Ms. Deng provides litigation support for ANDA cases and IP related contract disputes. She has working knowledge of U.S. FDA drug regulations. Ms. Deng worked as an extern in a Singapore law firm, focusing on international IP transactions. Ms. Deng is fluent in Mandarin Chinese and represents a few Chinese pharmaceutical companies.

Prior to her legal career, Ms. Deng worked as a scientist at Pfizer Inc., AbbVie, Inc., and BASF Pharma for 12 years. She designed and synthesized small and big molecules in the therapeutic areas ranging from immunology, oncology, inflammation, to neuroscience. She gained extensive experience in chemical process optimization and biological data evaluation. She was proficient at communicating with scientists in the chemical and pharmaceutical fields. Ms. Deng is an inventor of a patent entitled “4-aminopyrrolopyrimidines as kinase inhibitors”. She has co-authored several publications.

During college at Fudan University, she synthesized functional polymers and developed improved acrylic lacquer formulations for wood furniture.

Education

J.D., University of Connecticut School of Law
M.S., Brandeis University, Organic Chemistry
B.S., Fudan University, China, Polymer Chemistry

Honors/Awards

CALI Excellence Award for the Future in Income Taxation of Corporations & Shareholders, 2009
CALI Excellence Award for the Future in Clinic: Intellectual Property, 2008
Vice President and Treasurer of the Chinese Law Student Association, University of Connecticut School of Law, 2009
Gillette Fellowship, Brandeis University, 1996

Court admissions

U.S. Patent and Trademark Office
State of New York
State of Connecticut
U.S. District Court for the District of Connecticut
U.S. District Court for the Southern District of New York

Publications

  • “4-Aminopyrrolopyrimidines as Kinase Inhibitors”, U.S. Patent No. 7,863,444
  • “Studies on the Spectra of Poly(vinylcarbazole)-C60-C70 Charge-Transfer Complex”, Gaodeng Xuoxiao Huaxue Xuebao , 1994, 15(10), 1559062
  • “Studies on the Spectra of Poly(vinylcarbazole)-C60-C70 Charge-Transfer Complex”, 34th International Union of Pure and Applied Chemistry (IUPAC) Congress, Beijing, China, 1993, page 530

Presentations

  • “Patent Filing Strategy: U.S., China, or Elsewhere? Now or Later?”, Annual Conference of Chinese Association for Science and Technology in Connecticut , New Haven (Jan. 21, 2017)
  • “Patent Strategies in Drug Development and Approval in U.S. & Para. IV Case Study”, International Conference for Bioeconomy, organized by Ministry of Science and Technology of P. R. China, Tianjin, China (July 23-25, 2015)
  • “Structure Activity Relationships for a Novel Series of Pyrrolo[2,3-d]pyrimidine Tie-2 Inhibitors”, 93rd American Association for Cancer Research Annual Meeting San Francisco (2002)
  • “Synthesis and SAR of Pyrrolo[2,3]d-]pyrimidines Containing N-7 Substituents as Potent Inhibitors of LCK”, MEDI-110, 224th American Chemical Society National Meeting Boston (2002)
  • “Design, Synthesis and Brief SAR of Pyrazolo[3,4—d] and Pyrrolo[2,3]d-]pyrimidines as Potent Inhibitors of LCK”, MEDI-109, 224th American Chemical Society National Meeting Boston (2002)
986 Bedford Street, Stamford, Connecticut 06905-5619      +1 203 324-6155